Chinese regulators accused Baxter, the US drug company, of failing to co-operate in an investigation over deaths linked to impurities in blood thinner heparin.

The charge, swiftly denied by Baxter, marked a fresh escalation in Sino-US trade tensions since reports of at least 81 deaths linked to contaminated heparin in the US have triggered withdrawals in 11 countries.